| Execution period | 12 months |
|---|
NSE filing, NSE: WALPAR. Summary written from the filing by ALFA Finder's alert engine.
Walpar Nutritions Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹23.48 Cr
- Revenue (annual)
- ₹78.79 Cr
- Net profit (annual)
- ₹3.00 Cr
- P/E (TTM)
- 7.8×Sector 46.1×
- Promoter holding
- 68.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Walpar Nutritions Ltd
All →Walpar Nutritions Other Announcement
Walpar Nutritions filed a non-applicability intimation for corporate governance provisions under LODR, citing its SME listing. No transaction or business decision is involved.
Walpar Nutritions Annual General Meeting
Walpar Nutritions held its 6th AGM on 23 Sep 2026, approving routine resolutions on auditor re-appointment, director rotations, and related party transactions.
Walpar Nutritions Annual General Meeting
Walpar Nutritions Limited issued a notice for its Annual General Meeting to be held on August 23, 2026. The meeting agenda includes financial statement adoption and RPT approvals.
Walpar Nutritions Management Change
Walpar Nutritions Limited announced the re-appointment of four Independent Directors and its Statutory Auditor for fresh 60-month terms.
Walpar Nutritions Board Meeting Outcome
Walpar Nutritions Limited's board appointed statutory auditors for five years, re-appointed four independent directors, and approved holding the 6th AGM on September 23, 2026.
Walpar Nutritions Results Correction
Walpar Nutritions rectified a typographical error in its FY2025 XBRL filing regarding Consolidated Total Tax. The company confirmed no other changes to previously submitted financial information.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.